跳至主要内容
临床试验/NCT00831909
NCT00831909已完成不适用

Epidemiological Study to Describe Non-small Cell Lung Cancer (NSCLC) Clinical Management Patterns in Europe. Lung

AstraZeneca1 个研究点 分布在 1 个国家目标入组 3,513 人开始时间: 2009年1月最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
AstraZeneca
入组人数
3,513
试验地点
1
主要终点
To provide accurate, reliable information on NSCLC clinical management across European countries in order to detect unmet medical needs of this disease

研究概览

简要总结

To provide accurate and reliable information regarding NSCLC clinical management across European countries in order to detect unmet medical needs of this disease in terms of: patient and hospital characteristics; diagnostic and treatment approaches: initial and subsequent, follow-up patterns in clinical management; outcomes: symptoms, death, functionality, quality of life; use of resources and burden on patients and health care systems.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Confirmed NSCLC diagnosis (e.g. bronchoscope or FNAB), all stages, men and women, attending the responsible department of treating this type of patients for the first time between January 1st, 2009 and March 31st,
  • For PRO sub-sample: ability to read and write since they will be asked to participate in the PRO part of the study. Selection will not be based on the disease stage of each patient, in order to avoid a selection bias.

排除标准

  • According to the study design there will not be any exclusion criteria in order to provide a high external validity and to obtain the most accurate real daily practice information.

结局指标

主要结局

To provide accurate, reliable information on NSCLC clinical management across European countries in order to detect unmet medical needs of this disease

时间窗: 1 year follow up

次要结局

  • To assess the differences in patient characteristics, disease stage (differentiating between non-advanced disease, locally advanced disease, metastatic disease), and in clinical management across European countries.(1 year follow up)
  • To detect differences in clinical outcomes and related factors among countries.(1 year follow up)
  • To identify factors associated with clinical outcomes (patient, disease stage and clinical management related factors): predictive modelling for improved patient outcome.(1 year follow up)
  • To identify factors associated with the different levels of functional status and quality of life.(1 year follow up)
  • To compare the use of health care resources among countries.(1 year follow up)

研究者

发起方
AstraZeneca
申办方类型
Industry

研究点 (1)

Loading locations...

相似试验